Registre HEAR, Healthcare European Amyloidosis Registry
Recruiting
Observational Study
Cardiac Amyloidosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,000 (estimated)
- Sponsor
- Saving Lives Matters · Research network
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a non-interventional, prospective, retrospective, non-comparative, multi-center study.
In order not to interfere with patient management, the study is observational. Thus, no follow-up visit is imposed. The data collection will be limited to the data related to the management of the patients included throughout their follow-up.
This study is intended for all patients with a confirmed or …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
INCLUSION CRITERIA
1. Patients must meet all of the following inclusion criteria to be included in the study:
* Major patient
* Protected adult patient (guardianship or curatorship)
2. Prospective Cohort:
Patients referred or who have been referred to the participating centre for suspect…
Contacts